Aaron Pharmaceuticals Ltd and Others v Velvet Pharma Ltd (Miscellaneous Application No. 3013 of 2025)
Observed later treatment
No later-treatment classification is recorded for this judgment.
Citator coverage is limited to judgments in the Wakilii corpus and source-matched treatment records. Absence of a signal is not an assertion that the case remains good law.
AI-generated summary. This summary was generated by AI from the full text of the judgment. It may contain errors or omissions—always read the source judgment before relying on it.
Holding
The court granted the applicants unconditional leave to appear and defend a summary suit for recovery of debt. The applicants raised triable issues of law and fact regarding whether the first applicant was indebted to the respondent and to what extent, and whether the corporate veil should be lifted to sue individual directors. The reconciliation evidence was produced after suit was filed and the applicants were not involved in it, raising questions about the debt's verification.
Outcome
Applicants granted unconditional leave to defend the main suit
Facts
The respondent supplied pharmaceutical products to the first applicant on credit from January 2024 to June 2025. The respondent claimed the applicants owed UGX 1,878,335,964 after making partial payments until 1st July 2025. The respondent instituted a summary suit against the company and its four directors jointly and severally. The applicants disputed the debt, contending that all verified credit supplies had been paid and that unverified supplies remained unreconciled. The applicants also argued that the individual directors had never dealt with the respondent in their personal capacities. The respondent produced a reconciliation letter dated 29th January 2026 from accountants confirming the debt, but this was after the suit was filed on 20th November 2025. The respondent also produced tax invoices covering only January to February 2025, despite claiming supplies ran until June 2025.
Issues
- Whether the Applicants have raised sufficient grounds to warrant the grant of unconditional leave to appear and defend Civil Suit No. 1392 of 2025?
- What remedies are available to the parties?
Orders
- The Applicants are hereby granted unconditional leave to appear and defend Civil Suit No. 1392 of 2025.
- The Applicants shall file and serve their Written Statement of Defence within fifteen (15) days from the date of this Ruling.
- The Respondent shall file and serve its reply to the Written Statement of Defence within fifteen (15) days from the date of service of the Written Statement of Defence.
- Costs of this application shall be in the cause.
Rules and key headnotes
Legislation cited (6)
Cases cited (4)
- Oriental Insurance Brokers Limited v Transocean (U) Limited (Supreme Court Civil Appeal No. 55 of 1995)
- Maluku Interglobal Trade Agency Ltd v Bank of Uganda [1985] HCB 65
- Twentsche Overseas Trading Co. Ltd v Bombay Garage Ltd [1958] EA 741
- Churanjilal & Co. v A.H Adam (1950) 17 EACA 92
Full judgment
The original judgment as reported. Read the original PDF before relying on any passage.